Description
What Is Sprytiz?
Sprytiz is used to treat chronic myeloid leukaemia (CML) in adults, adolescents and children at least 1 year of age. Leukaemia is a cancer of white blood cells. These white cells usually help the body fight infection. In people with CLM, white cells called granulocytes start growing out of control. SPRYTIZ inhibits the growth of these leukaemic cells.
How Sprytiz Works?
Sprytiz is also used to treat Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukaemia (ALL) in adults, adolescents and children at least 1 year of age, and lymphoid blast CML in adults who are not benefiting from prior therapies. In people with ALL, white cells called lymphocytes multiply too quickly and live too long. SPRYTIZ inhibits the growth of these leukaemic cells.
How To Take Sprytiz?
The starting dose recommended for adult patients with chronic phase CML is 100 mg once a day. The starting dose recommended for adult patients with accelerated or blast crisis CML or Ph+ ALL is 140mg once a day.
📄 For More Information:
Download The Full Document Here:
Reviews
There are no reviews yet.